The voltage-gated potassium channel Kv1.3 constitutes an attractive pharmacological target for the treatment of effector memory T cell-mediated autoimmune diseases such as multiple sclerosis and psoriasis. Using 5-methoxypsoralen (5-MOP, 1), a compound isolated from Ruta graveolens, as a template we previously synthesized 5-(4-phenoxybutoxy)psoralen (PAP-1, 2) which inhibits Kv1.3 with an IC(50) of 2nM. Since PAP-1 is more than 1000-fold more potent than 5-MOP, we here investigated whether attaching a 4-phenoxybutoxy side chain to other heterocyclic systems would also produce potent Kv1.3 blockers. While 4-phenoxybutoxy-substituted quinolines, quinazolines and phenanthrenes were inactive, 4-phenoxybutoxy-substituted quinolinones, furoquinolines, coumarins or furochromones inhibited Kv1.3 with IC(50)s of 150 nM to 10 microM in whole-cell patch-clamp experiments. Our most potent new compound is 4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromene-7-thione (73, IC(50) 17 nM), in which the carbonyl oxygen of PAP-1 is replaced by sulfur. Taken together, our results demonstrate that the psoralen system is a crucial part of the pharmacophore of phenoxyalkoxypsoralen-type Kv1.3 blockers.
The voltage-gated potassium channel n class="Gene">Kv1.3 constitutes an attractive pharmacological target for the treatment of effector memory T cell-mediated autoimmune diseases such as multiple sclerosis and psoriasis. Using 5-methoxypsoralen (5-MOP, 1), a compound isolated from Ruta graveolens, as a template we previously synthesized 5-(4-phenoxybutoxy)psoralen (PAP-1, 2) which inhibits Kv1.3 with an IC(50) of 2nM. Since PAP-1 is more than 1000-fold more potent than 5-MOP, we here investigated whether attaching a 4-phenoxybutoxy side chain to other heterocyclic systems would also produce potent Kv1.3 blockers. While 4-phenoxybutoxy-substituted quinolines, quinazolines and phenanthrenes were inactive, 4-phenoxybutoxy-substituted quinolinones, furoquinolines, coumarins or furochromones inhibited Kv1.3 with IC(50)s of 150 nM to 10 microM in whole-cell patch-clamp experiments. Our most potent new compound is 4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromene-7-thione (73, IC(50) 17 nM), in which the carbonyl oxygen of PAP-1 is replaced by sulfur. Taken together, our results demonstrate that the psoralen system is a crucial part of the pharmacophore of phenoxyalkoxypsoralen-type Kv1.3 blockers.
Authors: G C Koo; J T Blake; A Talento; M Nguyen; S Lin; A Sirotina; K Shah; K Mulvany; D Hora; P Cunningham; D L Wunderler; O B McManus; R Slaughter; R Bugianesi; J Felix; M Garcia; J Williamson; G Kaczorowski; N H Sigal; M S Springer; W Feeney Journal: J Immunol Date: 1997-06-01 Impact factor: 5.422
Authors: Horea Rus; Carlos A Pardo; Lina Hu; Erika Darrah; Cornelia Cudrici; Teodora Niculescu; Florin Niculescu; Katharine M Mullen; Rameeza Allie; Liping Guo; Heike Wulff; Christine Beeton; Susan I V Judge; Douglas A Kerr; Hans-Gunther Knaus; K George Chandy; Peter A Calabresi Journal: Proc Natl Acad Sci U S A Date: 2005-07-25 Impact factor: 11.205
Authors: J P Felix; R M Bugianesi; W A Schmalhofer; R Borris; M A Goetz; O D Hensens; J M Bao; F Kayser; W H Parsons; K Rupprecht; M L Garcia; G J Kaczorowski; R S Slaughter Journal: Biochemistry Date: 1999-04-20 Impact factor: 3.162
Authors: Christine Beeton; Michael W Pennington; Heike Wulff; Satendra Singh; Daniel Nugent; George Crossley; Ilya Khaytin; Peter A Calabresi; Chao-Yin Chen; George A Gutman; K George Chandy Journal: Mol Pharmacol Date: 2005-01-21 Impact factor: 4.436
Authors: Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael W Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen Griffey; Hans-Guenther Knaus; Gerald T Nepom; George A Gutman; Peter A Calabresi; K George Chandy Journal: Proc Natl Acad Sci U S A Date: 2006-11-06 Impact factor: 11.205
Authors: Pavel I Zimin; Bojan Garic; Silke B Bodendiek; Cédrick Mahieux; Heike Wulff; Boris S Zhorov Journal: Mol Pharmacol Date: 2010-07-02 Impact factor: 4.436
Authors: Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič Journal: Med Res Rev Date: 2021-05-01 Impact factor: 12.944
Authors: Nefeli Slavi; Abduqodir H Toychiev; Stylianos Kosmidis; Jessica Ackert; Stewart A Bloomfield; Heike Wulff; Suresh Viswanathan; Paul D Lampe; Miduturu Srinivas Journal: Proc Natl Acad Sci U S A Date: 2018-06-11 Impact factor: 11.205
Authors: Roberta Peruzzo; Andrea Mattarei; Michele Azzolini; Katrin Anne Becker-Flegler; Matteo Romio; Giovanni Rigoni; Andrea Carrer; Lucia Biasutto; Sofia Parrasia; Stephanie Kadow; Antonella Managò; Andrea Urbani; Andrea Rossa; Gianpietro Semenzato; Maria Eugenia Soriano; Livio Trentin; Syed Ahmad; Michael Edwards; Erich Gulbins; Cristina Paradisi; Mario Zoratti; Luigi Leanza; Ildikò Szabò Journal: Redox Biol Date: 2020-09-06 Impact factor: 11.799